Introduction to Shanghai BioGerm Medical and Technology Co.,LTDBioGerm Established in March 2017,a high-tech company dedicated to the development and application of molecular diagnostic reagents for infectious pathogens.
- Deeply engaged in multiple fluorescent PCR diagnostic reagents and related technical services.
- 1600 square for R&D production and quality control of diagnostic reagents,with the certification in both ISO 91001 and13485.
- 1200 square for instrument production and sequencing.
- 1000square medical laboratory which is already qualified for molecular genetics and microbial testing, registered level 2 biosafety laboratory equipped with ABIQ5,ABI7500, Roche CobasZ480, Bio-Rad CFX9, Slan96 and other fluorescent PCR machines, Illumina and Ion Torrent second-generation sequencers and other equipment.
Simultaneous detection of the ORF1ab and N
- Dual-target gene: The dual-target gene is designed based on the target regions of the ORF1ab and the N gene encoding the specific nucleocapsid protein.
- The internal standard uses endogenous housekeeping gene to monitor the full process from sampling and detection to avoid false negative results.
- Approved by National Institutes for Food and Drug Control (national reference product)
- Approved by Beijing Center for Medical Device Quality Supervision and Testing of State Food and Drug Administration
- BioGerm's Nucleic Acid Detection Kit has already tested more than 2 million specimens in China at 321 units
The novel cor0navirus nucleic acid testing kit produced by BioGerm is the designated supplier for by the national health commission of PRC.